OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
m (→Schedule) |
m (→Schedule) |
||
| Line 55: | Line 55: | ||
| align="center" style="background:#f0f0f0;"|'''Topic''' | | align="center" style="background:#f0f0f0;"|'''Topic''' | ||
| align="center" style="background:#f0f0f0;"|'''Links & Comments''' | | align="center" style="background:#f0f0f0;"|'''Links & Comments''' | ||
| align="center" style="background:#f0f0f0;"|'''Location''' | |||
|-- | |-- | ||
| Line 61: | Line 62: | ||
|Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling | |Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling | ||
|Dr. Tania Vu’s lab in biomedical engineering | |Dr. Tania Vu’s lab in biomedical engineering | ||
| | |||
|-- | |-- | ||
| <font color=red>10/7/2011</font> | | <font color=red>10/7/2011</font> | ||
|Brett Sheppard | |Brett Sheppard | ||
|Pancreatic Cancer- Setting the Stage | |Pancreatic Cancer- Setting the Stage | ||
| | | | ||
| | |||
|-- | |-- | ||
|10/14/2011 | |10/14/2011 | ||
| Line 71: | Line 74: | ||
|Targeting cholinergic signaling in lung cancer | |Targeting cholinergic signaling in lung cancer | ||
|Dr. Eliot Spindel's lab: Neuroscience meets lung cancer and lung development | |Dr. Eliot Spindel's lab: Neuroscience meets lung cancer and lung development | ||
| | |||
|-- | |-- | ||
| <font color=red>10/21/2011</font> | | <font color=red>10/21/2011</font> | ||
|Soren Impey | |Soren Impey | ||
|Pancreas | |Pancreas | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 80: | Line 85: | ||
| | | | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 85: | Line 91: | ||
|Philip Streeter | |Philip Streeter | ||
|Pancreas: Immunoassays for Detection of Early Pancreatic Cancer | |Pancreas: Immunoassays for Detection of Early Pancreatic Cancer | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 90: | Line 97: | ||
|Joe Gray | |Joe Gray | ||
|Pancreas: “Subtyping pancreatic cancers – advancing diagnosis and treatment” | |Pancreas: “Subtyping pancreatic cancers – advancing diagnosis and treatment” | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 95: | Line 103: | ||
|Fox Lab | |Fox Lab | ||
|Pancreas | |Pancreas | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 100: | Line 109: | ||
|Rosie Sears | |Rosie Sears | ||
|Pancreas: | |Pancreas: | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 105: | Line 115: | ||
|Charles Springer | |Charles Springer | ||
|Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo? | |Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo? | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 110: | Line 121: | ||
| | | | ||
|Pancreas: Brain Storming | |Pancreas: Brain Storming | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 115: | Line 127: | ||
|CANCELLED | |CANCELLED | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 123: | Line 136: | ||
Shiuh-Wen Luoh | Shiuh-Wen Luoh | ||
| Breast Cancer: I-Spy-2 and tissue collection | | Breast Cancer: I-Spy-2 and tissue collection | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 129: | Line 143: | ||
Megan Troxell | Megan Troxell | ||
| Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions | | Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 134: | Line 149: | ||
|Joshi Alumkal | |Joshi Alumkal | ||
|Thinking Outside the (Androgen) Box in Prostate Cancer | |Thinking Outside the (Androgen) Box in Prostate Cancer | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 142: | Line 158: | ||
Jim Korkola | Jim Korkola | ||
| Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer | | Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 147: | Line 164: | ||
|Steven Jacques | |Steven Jacques | ||
|Label-free optical imaging of cellular processes | |Label-free optical imaging of cellular processes | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 154: | Line 172: | ||
| Breast Cancer: | | Breast Cancer: | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 159: | Line 178: | ||
|George Thomas | |George Thomas | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 165: | Line 185: | ||
Joe Gray | Joe Gray | ||
| Breast Cancer: | | Breast Cancer: | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 170: | Line 191: | ||
|Daniel Marks | |Daniel Marks | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 179: | Line 201: | ||
Xiangshu Xiao | Xiangshu Xiao | ||
| Breast Cancer: | | Breast Cancer: | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 184: | Line 207: | ||
|Jen Vomaske | |Jen Vomaske | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 189: | Line 213: | ||
|NO MEETING | |NO MEETING | ||
| Spring Break | | Spring Break | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 197: | Line 222: | ||
Sunjong Kwon | Sunjong Kwon | ||
| Breast Cancer: | | Breast Cancer: | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 202: | Line 228: | ||
|Lucia Carbone, PhD | |Lucia Carbone, PhD | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 210: | Line 237: | ||
Zhi Hu | Zhi Hu | ||
| Breast Cancer: | | Breast Cancer: | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 215: | Line 243: | ||
|Arthur Edwards | |Arthur Edwards | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 221: | Line 250: | ||
Koei Chin | Koei Chin | ||
| Breast Cancer: | | Breast Cancer: | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 226: | Line 256: | ||
|Wong Lab (Nick Smith, Emily Bubbers) | |Wong Lab (Nick Smith, Emily Bubbers) | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 231: | Line 262: | ||
| | | | ||
| Brainstorming | | Brainstorming | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 236: | Line 268: | ||
|Liskay Lab | |Liskay Lab | ||
|Modelling Sporadic Intestinal Cancer | |Modelling Sporadic Intestinal Cancer | ||
| | |||
| | | | ||
|-- | |-- | ||
| <font color=red>6/1/2012</font> | | <font color=red>6/1/2012</font> | ||
| | |||
| | | | ||
| | | | ||
| Line 246: | Line 280: | ||
|Kinrin Yamanaka (Dr. Stephen Lloyd lab) | |Kinrin Yamanaka (Dr. Stephen Lloyd lab) | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
| Line 251: | Line 286: | ||
|Neil Osheroff | |Neil Osheroff | ||
| | | | ||
| | |||
| | | | ||
|-- | |-- | ||
Revision as of 15:36, 7 February 2012
Home Faculty Graduate Program Postdocs OHSU Knight Core Facilities
Programs
Res Group Meetings
Cancer Journal Club
Cell/CANB 616
Gen. Inst/R3 Club
CANB 610
Objectives of the OHSU Knight Cancer Biology Research Group Meetings
Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:
- Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
- Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics
These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:
- Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
- Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.
Knight Research Group Activities
Want to join us? All are invited!
- To get on the listserve:
- go to the following web site:
- http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
- follow the instructions for subscribing
- We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
- Fridays 9:15-10:15 AM - see schedule below
- Breakfast provided by the Knight!
- Organizer: Rosie Sears, email searsrATohsu.edu
- Translational meeting organizer: Molly Kulesz-Martin, email kuleszma@ohsu.edu
Member Labs and Affiliations
Lopez Lab Hem Onc
Sears Lab, MMG
Hoatlin Lab, BMB
Thayer Lab, BMB
Lloyd Lab, CROET
McCullough Lab, CROET
Wong Lab, Dermatology, CDB
Zundel Lab, Radiation Medicine, Cancer Biology
Spindel Lab, Primate Center, NGP, Cancer Biology
- Add your lab here
Schedule
*Red indicates Translational Cancer Research Group Meetings
| Date | Presenters | Topic | Links & Comments | Location |
| 9/23/2011 | Thomas Jacob | Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling | Dr. Tania Vu’s lab in biomedical engineering | |
| 10/7/2011 | Brett Sheppard | Pancreatic Cancer- Setting the Stage | ||
| 10/14/2011 | Eliot Spindel | Targeting cholinergic signaling in lung cancer | Dr. Eliot Spindel's lab: Neuroscience meets lung cancer and lung development | |
| 10/21/2011 | Soren Impey | Pancreas | ||
| 10/28/2011 | ||||
| 11/4/2011 | Philip Streeter | Pancreas: Immunoassays for Detection of Early Pancreatic Cancer | ||
| 11/11/2011 | Joe Gray | Pancreas: “Subtyping pancreatic cancers – advancing diagnosis and treatment” | ||
| 11/18/2011 | Fox Lab | Pancreas | ||
| 12/2/2011 | Rosie Sears | Pancreas: | ||
| 12/9/2011 | Charles Springer | Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo? | ||
| 12/16/2011 | Pancreas: Brain Storming | |||
| 1/6/2012 | CANCELLED | |||
| 1/13/2012 |
Steve Chui Shiuh-Wen Luoh |
Breast Cancer: I-Spy-2 and tissue collection | ||
| 1/20/2012 |
Megan Troxell |
Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions | ||
| 1/27/2012 | Joshi Alumkal | Thinking Outside the (Androgen) Box in Prostate Cancer | ||
| 2/3/2012 |
Rosie Sears Jim Korkola |
Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer | ||
| 2/10/2012 | Steven Jacques | Label-free optical imaging of cellular processes | ||
| 2/17/2012 |
Lisa Coussens |
Breast Cancer: | ||
| 2/24/2012 | George Thomas | |||
| 3/2/2012 |
Joe Gray |
Breast Cancer: | ||
| 3/9/2012 | Daniel Marks | |||
| 3/16/2012 |
Paul Spellman Xiangshu Xiao |
Breast Cancer: | ||
| 3/23/2012 | Jen Vomaske | |||
| 3/30/2012 | NO MEETING | Spring Break | ||
| 4/6/2012 |
John Muschler Sunjong Kwon |
Breast Cancer: | ||
| 4/13/2012 | Lucia Carbone, PhD | |||
| 4/20/2012 |
Wassana Yantasee Zhi Hu |
Breast Cancer: | ||
| 4/27/2012 | Arthur Edwards | |||
| 5/4/2012 | Juha Rantala
Koei Chin |
Breast Cancer: | ||
| 5/11/2012 | Wong Lab (Nick Smith, Emily Bubbers) | |||
| 5/18/2012 | Brainstorming | |||
| 5/25/2012 | Liskay Lab | Modelling Sporadic Intestinal Cancer | ||
| 6/1/2012 | ||||
| 6/8/2012 | Kinrin Yamanaka (Dr. Stephen Lloyd lab) | |||
| 6/22/2012 | Neil Osheroff |
